By mimicking the effects of GLP-1, these patches help regulate insulin secretion, slow gastric emptying, and , making them an attractive option for individuals with type 2 diabetes or those seeking weight management solutions
Key Mergers and Acquisitions January 2026: Eli Lilly and Company acquired a biotech firm developing next-generation dual GLP-1/GIP agonists to expand its obesity and diabetes portfolio beyond Mounjaro and Zepbound
Total numbers of neurons and glial cells in cortex and basal ganglia of aged brains with Down syndromea stereological study
Probiotics Antimicrob Proteins 11:509518
Alternative Therapies May/Jun 2021 Vol
Physicians are trained to assess weight as a chronic, relapsing condition, and documenting failed lifestyle interventions builds the case that pharmacotherapy is appropriate rather than premature